These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20424526)

  • 1. Fatal reactivation of HBV and HDV during a long-lasting interruption of HAART in a patient co-infected with HIV, HCV, HBV and HDV.
    Polilli E; Sozio F; Mazzotta E; Pieri A; Alterio L; Placido E; Agostinone A; Di Masi F; Tontodonati M; Consorte A; Cosentino L; Parruti G
    Infez Med; 2010 Mar; 18(1):43-7. PubMed ID: 20424526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection.
    Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Prog Clin Biol Res; 1991; 364():207-10. PubMed ID: 2020697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection.
    Sellier P; Clevenbergh P; Mazeron MC; Cazals-Hatem D; Evans J; Cervoni J; Badsi E; Bendenoun M; Diemer M; Vincent V; Caulin C; Bergmann JF
    Scand J Infect Dis; 2004; 36(6-7):533-5. PubMed ID: 15307596
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K; Ringland C;
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain.
    Arribas JR; González-García JJ; Lorenzo A; Montero D; Ladrón de Guevara C; Montes M; Hernández S; Pacheco R; Peña JM; Vázquez JJ
    AIDS; 2005 Sep; 19(13):1361-5. PubMed ID: 16103766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.
    Béguelin C; Friolet N; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Atkinson A; Rauch A; Wandeler G;
    Clin Infect Dis; 2017 May; 64(9):1275-1278. PubMed ID: 28199492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.
    Lee CY; Tsai HC; Lee SS; Wu KS; Sy CL; Chen JK; Chen YS
    J Microbiol Immunol Infect; 2015 Feb; 48(1):20-7. PubMed ID: 24064291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis delta and HIV infection.
    Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
    Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.
    Eyster ME; Sanders JC; Battegay M; Di Bisceglie AM
    Dig Dis Sci; 1995 Jul; 40(7):1583-8. PubMed ID: 7628288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.
    Antonucci G; Vairo F; Iacomi F; Comandini UV; Solmone M; Piselli P; Boumis E; Lauria FN; Capobianchi MR; Ippolito G; Puro V
    Scand J Infect Dis; 2008; 40(11-12):928-34. PubMed ID: 18651264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
    Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
    J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.